Company intelligence / Profile preview

Magceutics

Hayward, California, United Statesmagceutics.com ↗

Ownership: Private
Employees: ~1
Development stage: Commercial

Overview

Magceutics commercializes Magtein®, a patented form of magnesium L-threonate clinically studied to increase brain magnesium, supporting cognitive function and memory. Preclinical research demonstrated reversal of memory deficits in Alzheimer's mouse models, and the product is well-tolerated as a dietary supplement in humans. The company focuses on science-backed nutraceuticals that cross the blood-brain barrier.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculeNutraceutical
Industry: Food & Nutrition

Drug pipeline

1 asset

Magtein

Commercial

Indications: Cognitive impairment, Memory disorders, Brain health

Partnerships

Tsinghua University, Beijing (academic collaboration for Alzheimer's research)

Beyond the preview

Go deeper on Magceutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magceutics.

Explore the full profile